Cart (0 Items)
Your cart is currently empty.
View ProductsBrand | ProteoGenix |
---|---|
Product type | Elisa assay kits |
Size | 96T |
Product name | Semorinemab ELISA Kit |
---|---|
Delivery condition | Blue ice (+4°) |
Storage condition | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
Brand | ProteoGenix |
Size | 96T |
Reference | KPTX167 |
Note | For research use only. |
Sample type | Plasma, Serum |
Immunogen | Semorinemab |
Semorinemab ELISA Kit is a highly sensitive and specific enzyme-linked immunosorbent assay (ELISA) kit designed for the quantitative measurement of Semorinemab in biological samples. The kit is composed of several components, including a microplate coated with a specific antibody, a Semorinemab standard, and detection reagents.
The microplate is made of high-quality polystyrene and is coated with a monoclonal antibody specific to Semorinemab. This antibody is immobilized on the surface of the microplate and serves as the capture antibody for Semorinemab. The microplate is designed to have 96 wells, allowing for the simultaneous testing of multiple samples.
The Semorinemab standard is included in the kit to allow for the quantification of Semorinemab in the samples. The standard is a known concentration of Semorinemab that is used to generate a standard curve. This curve is then used to determine the concentration of Semorinemab in the samples.
The detection reagents included in the kit are a biotinylated antibody and a streptavidin-HRP conjugate. The biotinylated antibody binds to Semorinemab in the sample, and the streptavidin-HRP conjugate binds to the biotinylated antibody. This results in the formation of a sandwich complex, with Semorinemab being captured between the two antibodies.
Semorinemab ELISA Kit is a highly sensitive and specific assay that utilizes the principle of sandwich ELISA. This technique allows for the detection and quantification of Semorinemab in biological samples.
The assay begins with the addition of the sample to the microplate coated with the capture antibody. The Semorinemab in the sample binds to the capture antibody, forming the first part of the sandwich complex. The biotinylated antibody is then added, which binds to the Semorinemab, forming the second part of the sandwich complex.
Next, the streptavidin-HRP conjugate is added, which binds to the biotinylated antibody. This results in the formation of a sandwich complex, with Semorinemab being captured between the two antibodies. The addition of a substrate for the HRP enzyme results in a color change, which is measured by a spectrophotometer.
The intensity of the color is directly proportional to the amount of Semorinemab present in the sample. By comparing the absorbance of the sample to the standard curve, the concentration of Semorinemab in the sample can be determined.
Semorinemab is a monoclonal antibody that is being developed as a potential therapeutic agent for the treatment of Alzheimer’s disease. It targets the beta-amyloid protein, which is believed to play a key role in the development and progression of Alzheimer’s disease.
The Semorinemab ELISA Kit is a valuable tool for researchers and clinicians studying Alzheimer’s disease and the potential therapeutic effects of Semorinemab. It allows for the accurate and precise measurement of Semorinemab in biological samples, providing important data for the development and evaluation of this potential therapeutic agent.
In addition to its application in Alzheimer’s disease research, the Semorinemab ELISA Kit can also be used in other studies involving Semorinemab, such as pharmacokinetic and pharmacodynamic studies. It is a versatile and reliable tool for the measurement of Semorinemab in various biological samples, making it an essential component of any research or clinical study involving this therapeutic target.
In conclusion, the Semorinemab ELISA Kit is a highly sensitive and specific assay that allows for the accurate and precise measurement of Semorinemab in biological samples. Its structure, activity, and application make it an essential tool for researchers and clinicians studying Alzheimer’s disease and the potential therapeutic effects of Semorinemab.
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.